Drug Database
Back to search

Germany· DE-A57-a89b66fce9486ba0

Amikacin B. Braun

A amikacin product containing amikacin, registered in Germany by B.Braun Melsungen Ag. The same ATC class is registered in 15 of our 19 countries.

ATC J01GB06

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedAmikacin B. BraunATCJ01GB06REGISTER NO.DE-A57-a89b66fce9486b…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amikacinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Amikacin is registered in 15 of 19 countries.

Countries holding a registration under ATC J01GB06 (amikacin), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 8 of them publish a price we can compare per daily dose
Search amikacin products by name

Amikacin · ATC J01GB06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Amikacin
Manufacturer
B.Braun Melsungen Ag
Country
Germany (DE)
ATC code
J01GB06
ATC class
Amikacin
Defined daily dose
0.59 g, Inhal
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

253 interactions on record for amikacin.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check amikacin against other medicinesHow interaction checks work

Amikacin · interactions on record

253 records

  • 50 severe
  • 133 moderate
  • 2 minor
  • 68 info

Most severe, free to view

  • Magnesium sulfateA06AD04severe
  • MannitolA06AD16severe
  • Polymyxin BA07AA05severe
  • Magnesium sulfateA12CC02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amikacin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amikacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Amikacin B. Braun
  • Belgium · Amikacine B. Braun, Amikacine Fresenius Kabi
  • Bulgaria · Amikacin Kabi, Амикацин Б. Браун
  • Cyprus · Amika-Synto, Amikacin Vioser
  • Czechia · Amikacin B. Braun, Amikacin Fresenius Kabi
  • Denmark · Amikacin Afortas, Amikacin Macure
  • Estonia · Amikacin B. Braun
  • Spain · Amicacina, Amicacina B. Braun
  • Finland · Amikacin Afortas, Amikacin Macure
  • France · Amikacine B. Braun, Amikacine Kabi
  • United Kingdom (Northern Ireland) · Amikacin Demo Pharma Uk, Amikacin Galvany Pharma
  • Greece · Amicasil, Amikacin Anfarm
  • Croatia · Amikacin Zentiva
  • Hungary · Amikacin Anfarm, Amikacin B. Braun
  • Ireland · Amikacin, Amikacin Athlone Pharmaceuticals
  • Iceland · Arikayce Liposomal
  • Italy · Amicasil, Amikacina B. Braun
  • Liechtenstein · Arikayce Liposomal
  • Lithuania · Biodacyna
  • Luxembourg · Amikacin B. Braun, Amukin
  • Latvia · Amikacin B.Braun
  • Malta · Amikacin Tillomed Laboratories, Uzix
  • Netherlands · Amikacine Hospira
  • Norway · Amikacin Afortas, Amikacin Macure
  • Poland · Amikacin B. Braun, Amikacin Kabi,
  • Portugal · Amicacina Hikma, Amicacina Kabi
  • Romania · Amikacin Noridem, Amikacină Atb
  • Sweden · Amikacin Afortas, Amikacin Fresenius Kabi
  • Slovenia · Amikacin Kabi
  • Slovakia · Amikacin B. Braun, Amikacin Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/12bb8d37-c2bc-4e2f-921d-525765ca58d1
GET /v1/drugs/12bb8d37-c2bc-4e2f-921d-525765ca58d1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Amikacin",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about amikacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console